Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.

Reitano KN, Kottilil S, Gille CM, Zhang X, Yan M, O'Shea MA, Roby G, Hallahan CW, Yang J, Lempicki RA, Arthos J, Fauci AS.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):1029-37. doi: 10.1089/aid.2008.0311.

2.

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD.

J Virol. 2009 Nov;83(21):11175-87. doi: 10.1128/JVI.00753-09. Epub 2009 Aug 19.

3.

HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.

Saïdi H, Bras M, Formaglio P, Melki MT, Charbit B, Herbeuval JP, Gougeon ML.

PLoS Pathog. 2016 Feb 12;12(2):e1005407. doi: 10.1371/journal.ppat.1005407. eCollection 2016 Feb.

4.

Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.

Benlahrech A, Gotch F, Kelleher P, Patterson S.

PLoS One. 2011 Mar 8;6(3):e17525. doi: 10.1371/journal.pone.0017525.

5.

Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

Chehimi J, Papasavvas E, Tomescu C, Gekonge B, Abdulhaqq S, Raymond A, Hancock A, Vinekar K, Carty C, Reynolds G, Pistilli M, Mounzer K, Kostman J, Montaner LJ.

J Virol. 2010 Mar;84(6):2762-73. doi: 10.1128/JVI.01350-09. Epub 2009 Dec 30.

6.

Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions.

Kottilil S, Shin K, Jackson JO, Reitano KN, O'Shea MA, Yang J, Hallahan CW, Lempicki R, Arthos J, Fauci AS.

J Immunol. 2006 Jan 15;176(2):1107-14.

7.

Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells.

Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M.

J Immunol. 2007 Jun 15;178(12):7658-66.

8.

HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.

Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, Arthos J, Fauci AS.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401. Epub 2007 Feb 20.

9.

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.

Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, Farschi A, Follmann D, Gregg R, Kovacs C, Marcenaro E, Pende D, Moretta A, Fauci AS.

J Exp Med. 2006 Oct 2;203(10):2339-50. Epub 2006 Sep 25.

10.

HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.

Cederarv M, Söderberg-Nauclér C, Odeberg J.

Immunobiology. 2009;214(5):331-41. doi: 10.1016/j.imbio.2008.10.009. Epub 2009 Jan 18.

PMID:
19152985
11.

Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay.

Hong HS, Bhatnagar N, Ballmaier M, Schubert U, Henklein P, Volgmann T, Heiken H, Schmidt RE, Meyer-Olson D.

Immunol Lett. 2009 Aug 15;125(2):100-4. doi: 10.1016/j.imlet.2009.06.008. Epub 2009 Jun 25.

PMID:
19559726
12.

Increased natural killer cell activity in viremic HIV-1 infection.

Alter G, Malenfant JM, Delabre RM, Burgett NC, Yu XG, Lichterfeld M, Zaunders J, Altfeld M.

J Immunol. 2004 Oct 15;173(8):5305-11.

13.

Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.

Martinet J, Dufeu-Duchesne T, Bruder Costa J, Larrat S, Marlu A, Leroy V, Plumas J, Aspord C.

Gastroenterology. 2012 Dec;143(6):1586-1596.e8. doi: 10.1053/j.gastro.2012.08.046. Epub 2012 Sep 6.

PMID:
22960656
14.

Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.

Tomescu C, Duh FM, Lanier MA, Kapalko A, Mounzer KC, Martin MP, Carrington M, Metzger DS, Montaner LJ.

AIDS. 2010 Sep 10;24(14):2151-60. doi: 10.1097/QAD.0b013e32833dfc20.

15.

Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation.

Barblu L, Machmach K, Gras C, Delfraissy JF, Boufassa F, Leal M, Ruiz-Mateos E, Lambotte O, Herbeuval JP; ANRS EP36 HIV Controllers Study Group..

J Infect Dis. 2012 Sep 1;206(5):790-801. Epub 2012 Jun 12.

PMID:
22693234
17.

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L.

Viral Immunol. 2011 Oct;24(5):359-68. doi: 10.1089/vim.2011.0025. Epub 2011 Sep 29.

PMID:
21958370
18.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, Kinter A, Kovacs C, Moretta A, Fauci AS.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91. Epub 2005 Feb 7.

19.

Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells.

Søndergaard JN, Vinner L, Brix S.

Mol Immunol. 2014 Jun;59(2):180-7. doi: 10.1016/j.molimm.2014.02.009. Epub 2014 Mar 13.

PMID:
24632372
20.

Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection?

Gougeon ML, Bras M.

Curr Opin HIV AIDS. 2011 Sep;6(5):364-72. doi: 10.1097/COH.0b013e328349b089. Review.

PMID:
21825870

Supplemental Content

Support Center